YZ
Yun Zhong Wedbush Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
25
Avg Return
Past Year
Past Year
33%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
87%
Neutral
13%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Maintained
| $10 |
74%
upside
| 2 | +81% |
0
%
| 12 Mar ‘26 1 month ago |
|
|
|
Outperform
Maintained
| $35 |
367%
upside
| 4 | +30% |
0
%
| 6 Mar ‘26 1 month ago |
|
|
|
Outperform
Maintained
| $8 |
182%
upside
| 1 | -5.8% |
0
%
| 5 Mar ‘26 1 month ago |
|
|
|
Outperform
Maintained
| $273 |
12%
upside
| 4 | +8.4% |
0
%
| 12 Feb ‘26 2 months ago |
|
|
|
Outperform
Maintained
| $34 |
58%
upside
| 2 | -12% |
0
%
| 23 Jan ‘26 2 months ago |
|
|
|
Neutral
Maintained
| $2 |
42%
downside
| 1 | +64% |
–
| 8 Jan ‘26 3 months ago |
|
|
|
Neutral
Maintained
| $16 |
37%
upside
| 3 | – |
–
| 6 Nov ‘25 5 months ago |
|
|
|
Outperform
Maintained
| $86 |
19%
downside
| 2 | +40% |
0
%
| 28 Oct ‘25 5 months ago |
|
|
|
Outperform
Maintained
| $18 |
2%
downside
| 1 | +168% |
0
%
| 30 Sep ‘25 6 months ago |
|
|
|
Outperform
Maintained
| $40 |
243%
upside
| 1 | +35% |
0
%
| 13 Aug ‘25 8 months ago |
|
|
|
Outperform
Initiated
| $28 |
333%
upside
| 1 | -41% |
0
%
| 11 Aug ‘25 8 months ago |
|
|
|
Outperform
Maintained
| $8 |
94%
upside
| 1 | +30% |
0
%
| 7 Aug ‘25 8 months ago |
|
|
|
Outperform
Initiated
| $8 |
78%
upside
| 1 | +170% |
0
%
| 27 May ‘25 10 months ago |
|
|
|
Outperform
Reiterated
| $32 |
718%
upside
| 1 | -28% |
0
%
| 16 May ‘25 11 months ago |
|